Literature DB >> 25930952

Catehol-o-methyltransferase gene Val158met polymorphism as a potential predictor of response to computer-assisted delivery of cognitive-behavioral therapy among cocaine-dependent individuals: Preliminary findings from a randomized controlled trial.

Kathleen M Carroll1, Aryeh Herman1, Elise E DeVito1, Tami L Frankforter1, Marc N Potenza1, Mehmet Sofuoglu1.   

Abstract

BACKGROUND: Findings from uncontrolled studies suggest that the COMT Val108/158Met polymorphism may affect response to cognitive behavioral therapy (CBT) in some populations. Using data from a randomized controlled trial evaluating computerized CBT (CBT4CBT), we evaluated treatment response by COMT genotype, with the a priori hypothesis that Val carriers would have improved response to computerized delivery of CBT.
METHODS: 101 cocaine-dependent individuals, of whom 81 contributed analyzable genetic samples, were randomized to standard methadone maintenance treatment plus CBT4CBT or standard treatment alone in an 8 week trial.
RESULTS: There was a significant genotype by time effect on frequency of cocaine use from baseline to the end of the 6 month follow-up, suggesting greater reductions over time for Val carriers relative to individuals with the Met/Met genotype. There was a significant treatment condition by genotype interactions for rates of participants attaining 21 or more days of continuous abstinence as well as self-reported percent days of abstinence, suggesting less cocaine use among Val carriers when assigned to CBT compared to standard treatment. Exploration of possible mechanisms using measures of attentional biased also pointed to greater change over time in these measures among the Val carriers assigned to CBT.
CONCLUSION: These are the first data from a randomized controlled trial indicating significant interactions of COMT polymorphism and behavioral therapy condition on treatment outcome, where Val carriers appeared to respond particularly well to computerized CBT. These preliminary data point to a potential biomarker of response to CBT linked to its putative mechanism of action, enhanced cognitive control. © American Academy of Addiction Psychiatry.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25930952      PMCID: PMC4516567          DOI: 10.1111/ajad.12238

Source DB:  PubMed          Journal:  Am J Addict        ISSN: 1055-0496


  49 in total

1.  Electrophysiological evidence of early attentional bias to drug-related pictures in chronic cannabis users.

Authors:  Deyar Asmaro; Patrick L Carolan; Mario Liotti
Journal:  Addict Behav       Date:  2013-09-14       Impact factor: 3.913

Review 2.  A new intellectual framework for psychiatry.

Authors:  E R Kandel
Journal:  Am J Psychiatry       Date:  1998-04       Impact factor: 18.112

3.  Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals.

Authors:  E Carboni; G L Tanda; R Frau; G Di Chiara
Journal:  J Neurochem       Date:  1990-09       Impact factor: 5.372

4.  Therapygenetics: moving towards personalized psychotherapy treatment.

Authors:  Christopher G Beevers; John E McGeary
Journal:  Trends Cogn Sci       Date:  2011-11-19       Impact factor: 20.229

5.  Pharmacogenomics and personalized medicine in neuropsychiatry.

Authors:  Francis J McMahon; Thomas R Insel
Journal:  Neuron       Date:  2012-06-07       Impact factor: 17.173

6.  Contingent reinforcement increases cocaine abstinence during outpatient treatment and 1 year of follow-up.

Authors:  S T Higgins; C J Wong; G J Badger; D E Ogden; R L Dantona
Journal:  J Consult Clin Psychol       Date:  2000-02

Review 7.  Neuroimaging and the functional neuroanatomy of psychotherapy.

Authors:  Joshua L Roffman; Carl D Marci; Debra M Glick; Darin D Dougherty; Scott L Rauch
Journal:  Psychol Med       Date:  2005-10       Impact factor: 7.723

8.  Enduring effects of a computer-assisted training program for cognitive behavioral therapy: a 6-month follow-up of CBT4CBT.

Authors:  Kathleen M Carroll; Samuel A Ball; Steve Martino; Charla Nich; Theresa A Babuscio; Bruce J Rounsaville
Journal:  Drug Alcohol Depend       Date:  2008-11-28       Impact factor: 4.492

9.  Association between the catechol-O-methyltransferase Val158Met polymorphism and cocaine dependence.

Authors:  Falk W Lohoff; Andrew E Weller; Paul J Bloch; Aleksandra H Nall; Thomas N Ferraro; Kyle M Kampman; Helen M Pettinati; David W Oslin; Charles A Dackis; Charles P O'Brien; Wade H Berrettini
Journal:  Neuropsychopharmacology       Date:  2008-08-13       Impact factor: 7.853

Review 10.  Psychotherapy and brain plasticity.

Authors:  Daniel Collerton
Journal:  Front Psychol       Date:  2013-09-06
View more
  3 in total

1.  COMT Val158Met Polymorphism and Symptom Improvement Following a Cognitively Focused Intervention for Irritable Bowel Syndrome.

Authors:  Claire J Han; Ruth Kohen; Sangeun Jun; Monica E Jarrett; Kevin C Cain; Robert Burr; Margaret M Heitkemper
Journal:  Nurs Res       Date:  2017 Mar/Apr       Impact factor: 2.381

2.  Computerized Cognitive Behavioral Therapy for Substance Use Disorders: A Summary of the Evidence and Potential Mechanisms of Behavior Change.

Authors:  Brian D Kiluk
Journal:  Perspect Behav Sci       Date:  2019-06-05

Review 3.  Blending Face-to-Face and Internet-Based Interventions for the Treatment of Mental Disorders in Adults: Systematic Review.

Authors:  Doris Erbe; Hans-Christoph Eichert; Heleen Riper; David Daniel Ebert
Journal:  J Med Internet Res       Date:  2017-09-15       Impact factor: 5.428

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.